Cite

    D Choquette et al.. “AB0397 Abatacept shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry.” Annals of the rheumatic diseases, vol. 76, n.d., p. 1188. http://access.bl.uk/ark:/81055/vdc_100135134314.0x000061